QA: ENZO Biochem INC in us_health_services/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000316253_2015_ENZO_Biochem_INC.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.008121497604158206, 'aggregate_val': 24826000, 'exp_sum': 24626000, 'exp_to_value': {'LongTermLiabilities': 774000, 'LiabilitiesCurrent': 23852000, 'remainder_Liabilities': 0}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.006708702984089742, 'aggregate_val': 27461000, 'exp_sum': 27278000, 'exp_to_value': {'LongTermLiabilities': 2313000, 'LiabilitiesCurrent': 24965000, 'remainder_Liabilities': 0}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000316253, ENZO Biochem INC

  xvar xval
0 IntangibleAssets 15,560,000
1 AssetsNonCurrent 385,000
2 AssetsCurrent 40,736,000
3 PropertyPlantAndEquipment 7,730,000
4 remainder_Assets 0
5 LongTermLiabilities 2,313,000
6 LiabilitiesCurrent 24,965,000
7 remainder_Liabilities 183,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 0
10 GeneralAndAdministrativeExpense 41,801,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 3,141,000
16 remainder_Expenses 61,257,000
17 remainder_Revenues 95,947,000
18 remainder_NetIncome 275,000
19 remainder_ComprehensiveNetIncome -114,000
  yvar yval
0 Assets 64,411,000
1 Liabilities 27,461,000
2 Expenses 106,199,000
3 Revenues 95,947,000
4 StockholdersEquity 36,950,000
5 NetIncome -9,977,000
6 ComprehensiveNetIncome -10,091,000
7 BaseVar 147,203,500
8 EconomicCapitalRatio 2.02

Edgar->Model Mapping

Feature Distribution

Change over Time